Skip to main content
. 2009 Dec 22;102(2):316–324. doi: 10.1038/sj.bjc.6605489

Table 1. Average IC50 values of STX140, STX243, STX66, paclitaxel, ENMD1198, vinorelbine and colchicine in (a) MCF-7 and (b) MDA-MB-231 cells.

MCF-7 cells Avg IC50 values (μM) Mock pALTER-TUBB3 siRNA-tubb3
(a)      
STX140 0.98 1.06 0.92
STX243 0.69 0.81 0.73
2-MeOE2 0.99 0.97 0.98
Paclitaxel 7.2 × 10−6 1 × 10−4** 4.8 × 10−6*
Vinorelbine 0.06 1** 0.01*
ENMD1198 0.57 0.61 0.45
Colchicine 0.024 0.029 0.029
       
MDA-MB-231 cells Avg IC50 values (μM) Mock pALTER-TUBB3 siRNA-tubb3
(b)      
STX140 0.05 0.08 0.07
STX243 0.08 0.10 0.09
2-MeOE2 0.99 0.98 0.99
Paclitaxel 2 × 10−6 4 × 10−6*** <1 × 10−7**
Vinorelbine 0.12 0.25** 0.12
ENMD1198 0.08 0.09 0.09
Colchicine 0.037 0.042 0.029

Cells were transfected with pALTER-TUBB3 or siRNA-tubb3. They were then exposed to STX140, STX243, paclitaxel, STX66, ENMD1198, vinorelbine or colchicine for 4 days and the IC50 values were obtained from a graph of percent proliferation vs inhibitor concentration and calculated using Prism (Graphpad Software). ***P<0.001, **P<0.01 and *P<0.05.

HHS Vulnerability Disclosure